Free Trial

Intech Investment Management LLC Boosts Stake in Cinemark Holdings, Inc. (NYSE:CNK)

Cinemark logo with Consumer Discretionary background
Remove Ads

Intech Investment Management LLC grew its position in shares of Cinemark Holdings, Inc. (NYSE:CNK - Free Report) by 28.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 61,943 shares of the company's stock after purchasing an additional 13,788 shares during the quarter. Intech Investment Management LLC owned approximately 0.05% of Cinemark worth $1,919,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Quarry LP grew its position in Cinemark by 714.8% during the third quarter. Quarry LP now owns 1,491 shares of the company's stock valued at $42,000 after acquiring an additional 1,308 shares during the last quarter. R Squared Ltd purchased a new stake in shares of Cinemark in the 4th quarter valued at $63,000. GAMMA Investing LLC grew its holdings in shares of Cinemark by 44.9% during the 4th quarter. GAMMA Investing LLC now owns 2,926 shares of the company's stock valued at $91,000 after purchasing an additional 906 shares during the last quarter. Smartleaf Asset Management LLC raised its position in Cinemark by 198.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 3,320 shares of the company's stock worth $103,000 after purchasing an additional 2,207 shares during the period. Finally, Quest Partners LLC bought a new stake in Cinemark in the third quarter worth $115,000.

Insider Buying and Selling

In other Cinemark news, insider Wanda Marie Gierhart sold 9,119 shares of Cinemark stock in a transaction that occurred on Tuesday, February 25th. The shares were sold at an average price of $27.00, for a total value of $246,213.00. Following the completion of the sale, the insider now owns 147,414 shares of the company's stock, valued at approximately $3,980,178. The trade was a 5.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.30% of the stock is owned by company insiders.

Remove Ads

Cinemark Stock Up 1.1 %

Shares of NYSE:CNK traded up $0.29 during trading on Tuesday, hitting $25.66. The stock had a trading volume of 2,863,394 shares, compared to its average volume of 2,807,421. The company has a quick ratio of 0.96, a current ratio of 1.01 and a debt-to-equity ratio of 3.28. Cinemark Holdings, Inc. has a 12 month low of $16.32 and a 12 month high of $36.28. The company has a market capitalization of $3.14 billion, a PE ratio of 12.64 and a beta of 2.41. The firm's fifty day moving average is $27.82 and its 200 day moving average is $29.49.

Cinemark (NYSE:CNK - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The company reported $0.33 EPS for the quarter, missing the consensus estimate of $0.39 by ($0.06). The business had revenue of $814.30 million for the quarter, compared to the consensus estimate of $797.18 million. Cinemark had a return on equity of 65.83% and a net margin of 10.16%. The company's revenue was up 27.5% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.15) EPS. Analysts anticipate that Cinemark Holdings, Inc. will post 1.93 EPS for the current fiscal year.

Cinemark Dividend Announcement

The company also recently disclosed a -- dividend, which was paid on Wednesday, March 19th. Shareholders of record on Wednesday, March 5th were paid a dividend of $0.08 per share. The ex-dividend date of this dividend was Wednesday, March 5th. Cinemark's dividend payout ratio is currently 15.76%.

Analyst Ratings Changes

Several research firms have recently commented on CNK. Morgan Stanley decreased their price objective on Cinemark from $40.00 to $35.00 and set an "overweight" rating on the stock in a report on Thursday, February 20th. Wedbush reaffirmed a "neutral" rating and issued a $32.00 price target on shares of Cinemark in a research note on Tuesday, February 18th. Barrington Research reissued an "outperform" rating and set a $40.00 price objective on shares of Cinemark in a research note on Wednesday, February 19th. Benchmark decreased their target price on shares of Cinemark from $40.00 to $35.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Finally, Macquarie reiterated an "outperform" rating and set a $35.00 price target on shares of Cinemark in a report on Thursday, February 20th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Cinemark currently has an average rating of "Moderate Buy" and a consensus target price of $32.70.

Get Our Latest Stock Report on CNK

About Cinemark

(Free Report)

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.

Featured Articles

Institutional Ownership by Quarter for Cinemark (NYSE:CNK)

Should You Invest $1,000 in Cinemark Right Now?

Before you consider Cinemark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cinemark wasn't on the list.

While Cinemark currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads